MNPR vs. CALX
Compare and contrast key facts about Monopar Therapeutics Inc. (MNPR) and Calix, Inc. (CALX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MNPR or CALX.
Key characteristics
| MNPR | CALX | |
|---|---|---|
| YTD Return | 853.53% | -13.62% |
| 1Y Return | 702.48% | 14.50% |
| 3Y Return (Ann) | -12.31% | -15.57% |
| Sharpe Ratio | 0.95 | 0.36 |
| Sortino Ratio | 8.00 | 0.72 |
| Omega Ratio | 2.04 | 1.12 |
| Calmar Ratio | 6.11 | 0.24 |
| Martin Ratio | 14.04 | 0.78 |
| Ulcer Index | 43.09% | 19.70% |
| Daily Std Dev | 635.81% | 43.30% |
| Max Drawdown | -98.93% | -80.95% |
| Current Drawdown | -87.99% | -52.81% |
Fundamentals
| MNPR | CALX | |
|---|---|---|
| Market Cap | $62.29M | $2.60B |
| EPS | -$2.30 | -$0.28 |
| Total Revenue (TTM) | $0.00 | $689.18M |
| EBITDA (TTM) | -$5.42M | -$7.79M |
Correlation
The correlation between MNPR and CALX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MNPR vs. CALX - Performance Comparison
In the year-to-date period, MNPR achieves a 853.53% return, which is significantly higher than CALX's -13.62% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MNPR vs. CALX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Monopar Therapeutics Inc. (MNPR) and Calix, Inc. (CALX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MNPR vs. CALX - Dividend Comparison
Neither MNPR nor CALX has paid dividends to shareholders.
Drawdowns
MNPR vs. CALX - Drawdown Comparison
The maximum MNPR drawdown since its inception was -98.93%, which is greater than CALX's maximum drawdown of -80.95%. Use the drawdown chart below to compare losses from any high point for MNPR and CALX. For additional features, visit the drawdowns tool.
Volatility
MNPR vs. CALX - Volatility Comparison
Monopar Therapeutics Inc. (MNPR) has a higher volatility of 213.90% compared to Calix, Inc. (CALX) at 9.95%. This indicates that MNPR's price experiences larger fluctuations and is considered to be riskier than CALX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MNPR vs. CALX - Financials Comparison
This section allows you to compare key financial metrics between Monopar Therapeutics Inc. and Calix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities